Toronto, ON, Dec. 12, 2019 (GLOBE NEWSWIRE) — The low survival rates of three of the four most lethal cancers in North America – pancreatic, colorectal and lung – are associated with KRAS mutations, a well-established cancer driver. Although there is an urgent need for…
